Trial · NCT03259074
Results by group23
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 23
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With no Radiographic Progression at Week 104 (Multiple Imputation) (Full Analysis Set) | AIN457 150 mg/Placebo | 66.1 | Percentage of participants | ||
| Percentage of Participants With no Radiographic Progression at Week 104 (Multiple Imputation) (Full Analysis Set) | AIN457 300 mg | 66.9 | Percentage of participants | ||
| Percentage of Participants With no Radiographic Progression at Week 104 (Multiple Imputation) (Full Analysis Set) | GP2017 40mg | 65.6 | Percentage of participants | ||
| Change From Baseline in mSASSS at Week 104 (Multiple Imputation) (Full Analysis Set) | AIN457 150 mg/Placebo | 0.54 | Standard Error 0.175 | mSASSS scores | |
| Change From Baseline in mSASSS at Week 104 (Multiple Imputation) (Full Analysis Set) | AIN457 300 mg | 0.55 | Standard Error 0.180 | mSASSS scores | |
| Change From Baseline in mSASSS at Week 104 (Multiple Imputation) (Full Analysis Set) | GP2017 40mg | 0.72 | Standard Error 0.177 | mSASSS scores | |
| Percentage of Participants Without New Syndesmophytes by mSASSS Between Baseline and Week 104 (Multiple Imputation) (Syndesmophyte Subset) | AIN457 150 mg/Placebo | 56.9 | Percentage of participants | ||
| Percentage of Participants Without New Syndesmophytes by mSASSS Between Baseline and Week 104 (Multiple Imputation) (Syndesmophyte Subset) | AIN457 300 mg | 53.8 | Percentage of participants | ||
| Percentage of Participants Without New Syndesmophytes by mSASSS Between Baseline and Week 104 (Multiple Imputation) (Syndesmophyte Subset) | GP2017 40mg | 53.3 | Percentage of participants | ||
| Change From Baseline in MRI Berlin Sacroiliac (SI) Joint Edema Score (Observed Data) (MRI Subset) | AIN457 150 mg/Placebo | -1.527 | Standard Error 0.1057 | scores on a scale | |
| Change From Baseline in MRI Berlin Sacroiliac (SI) Joint Edema Score (Observed Data) (MRI Subset) | AIN457 300 mg | -1.378 | Standard Error 0.1097 | scores on a scale | |
| Change From Baseline in MRI Berlin Sacroiliac (SI) Joint Edema Score (Observed Data) (MRI Subset) | GP2017 40mg | -1.710 | Standard Error 0.1087 | scores on a scale | |
| Change From Baseline in Berlin Modification of ASspiMRI-a Edema Score (MRI Subset) | AIN457 150 mg/Placebo | -1.224 | Standard Error 0.2306 | Berlin mod. of ASspiMRI-a edema scores | |
| Change From Baseline in Berlin Modification of ASspiMRI-a Edema Score (MRI Subset) | AIN457 300 mg | -1.683 | Standard Error 0.2373 | Berlin mod. of ASspiMRI-a edema scores | |
| Change From Baseline in Berlin Modification of ASspiMRI-a Edema Score (MRI Subset) | GP2017 40mg | -2.101 | Standard Error 0.2378 | Berlin mod. of ASspiMRI-a edema scores | |
| Percentage of Responders for Assessment of SpondyloArthritis International Society 20 (ASAS20) | AIN457 150 mg/Placebo | 83.1 | 95% Confidence Interval 77.8 to 87.4 | Percentage of participants | |
| Percentage of Responders for Assessment of SpondyloArthritis International Society 20 (ASAS20) | AIN457 300 mg | 82.9 | 95% Confidence Interval 77.3 to 87.4 | Percentage of participants | |
| Percentage of Responders for Assessment of SpondyloArthritis International Society 40 (ASAS 40) | AIN457 150 mg/Placebo | 69.9 | 95% Confidence Interval 63.7 to 75.4 | Percentage of participants | |
| Percentage of Responders for Assessment of SpondyloArthritis International Society 40 (ASAS 40) | AIN457 300 mg | 73.5 | 95% Confidence Interval 67.3 to 78.9 | Percentage of participants | |
| Percentage of Responders for Assessment of SpondyloArthritis International Society With a Partial Remission Response (Full Analysis Set) | AIN457 150 mg/Placebo | 31.5 | 95% Confidence Interval 25.9 to 37.7 | Percentage participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03259074/results